Yale University - Pharmaceuticals & Healthcare - Deals and Alliances Profile - GlobalData Financial Mergers and Acquisitions Intelligence

Yale University - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Yale University - Pharmaceuticals & Healthcare - Deals and Alliances Profile - GlobalData Financial Mergers and Acquisitions Intelligence
Yale University - Pharmaceuticals & Healthcare - Deals and Alliances Profile
Published Sep 27, 2016
39 pages — Published Sep 27, 2016
Price US$ 250.00  |  Buy this Report Now

About This Report

  
Abstract:

Summary

Yale University (Yale) is a research and educational institution that provides educational programs and educational courses. The institution provides courses such as graduate, undergraduate, professional and distance learning programs, and summer courses. Its academic programs offers African American studies, anesthesiology, anthropology, applied mathematics, applied physics, astronomy, cell biology, classics, African studies, Agrarian studies, biological and biomedical sciences, biostatistics, British studies, chemistry, comparative literature, and dermatology, and others.

Yale University - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharmaceuticals & Healthcare eTrack deals database, and primary and secondary research.


Scope

- Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the company's operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.


Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal

  
Source:
Document ID
GDPH142298D
Country
Industry
Format:
PDF Adobe Acrobat
Buy Now

Sections

TitleStarting PageNumber of Pages
Table of Contents23
  List of Tables31
  List of Figures41
Yale University, Pharmaceuticals &Healthcare, Deals By Year, 2010 to YTD 201642
Yale University, Pharmaceuticals &Healthcare Deals By Type, 2010 to YTD 201661
Yale University, Pharmaceuticals &Healthcare, Deals By Region, 2010 to YTD 201671
Yale University, Pharmaceuticals &Healthcare, Deals By Therapy Area, 2010 to YTD 201681
Yale University, Medical Devices Deals, 2010 to YTD 201691
Yale University, Pharmaceuticals &Healthcare, Deals Summary, 2010 to YTD 2016102
Yale University, Pharmaceuticals &Healthcare, Deal Details1224
  Venture Financing121
    IsoPlexis Raises USD1.3 Million in Series A Financing121
    New Haven Pharma Raises US$7 Million In Series A Financing132
  Partnerships151
    Organovo Enters into Co-Development Agreement with Yale School of Medicine151
    GlaxoSmithKline Enters into Partnership with Yale University161
    Evotec Enters Into Research Agreement With Yale University For Cancer Therapy171
    Novogen Forms Joint Venture With Yale University182
    CaroGen Enters into Research Agreement with Yale University201
    GlaxoSmithKline Enters Into Co-Development Agreement With Yale University211
    Unigene Labs Terminates Research And License Agreement With Yale University221
    Amway Enters Into Co-Development Agreement With Yale University231
    Gilead Sciences Enters Into Research Collaboration With Yale School of Medicine241
  Licensing Agreements251
    Kleo Pharma Enters into Licensing Agreement with Yale University251
    Kadmon Terminates Licensing Agreement with Yale University261
    Patrys Enters into Licensing Agreement with Yale University271
    Modulate Therapeutics Enters into Licensing Agreement with Yale University and Immunova281
    Allied-Bristol Life Sciences Enters into Licensing agreement with Yale University291
    Debiopharm Enters Into Licensing Agreement With Yale University302
    Immunova Enters into Licensing Agreement with Yale University321
    CaroGen Enters into Licensing Agreement with Yale University331
    Medistem Enters Into Licensing Agreement With Yale University For Type 1 Diabetes341
    Debiopharm Enters Into Licensing Agreement With Yale University For Debio 1036351
Yale University - Key Competitors361
Key Employees371
Locations And Subsidiaries381
  Head Office381
  Other Locations &Subsidiaries381
Appendix391
  Methodology391
  About GlobalData391
  Contact Us391
  Disclaimer391

Table Of Contents

About the Author


Cite this Report

  
MLA:
GlobalData Financial Mergers and Acquisitions Intelligence. "Yale University - Pharmaceuticals & Healthcare - Deals and Alliances Profile" Sep 27, 2016. Alacra Store. Nov 16, 2026. <http://www.alacrastore.com/storecontent/GlobalData-Financial-Mergers-and-Acquisitions-Intelligence/Yale-University-Pharmaceuticals-Healthcare-Deals-and-Alliances-Profile-2148-17169>
  
APA:
GlobalData Financial Mergers and Acquisitions Intelligence. (2016). Yale University - Pharmaceuticals & Healthcare - Deals and Alliances Profile Sep 27, 2016. New York, NY: Alacra Store. Retrieved Nov 16, 2026 from <http://www.alacrastore.com/storecontent/GlobalData-Financial-Mergers-and-Acquisitions-Intelligence/Yale-University-Pharmaceuticals-Healthcare-Deals-and-Alliances-Profile-2148-17169>
  
US$ 250.00
$  £  €
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research